Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.06% 834.50p 834.00p 834.50p 835.00p 834.00p 835.00p 25,404 10:11:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 620.5 -70.6 3.9 214.0 3,233.11

Btg Share Discussion Threads

Showing 5226 to 5247 of 6175 messages
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
05/4/2018
11:17
Unless I'm mistaken, the impairment charge will be a balance sheet change, resulting in a profit loss which will reduce the tax burden on btg for this year, creating tax losses which can be put against future profits.The key factor to watch will be the net cash at year end and analysts will look at this in the forecasts for 2018/9.The board and Mr Woodford will be asking the executives whether there are any more major write downs to come before the long term shape of the group comes clear and dividend policy will be a key feature of this.It's going to be 2/3 years before this comes through and I'm not sure the market and key investors will have the patience.
fhmktg
05/4/2018
10:40
Woodford days are well and truly over. Must have liquidity issues and btg is one of the more liquid assets so wouldn't be surprised to see him sell down. Pe is still way to high.
waterloo01
05/4/2018
10:33
Way over sold here - Buying a plenty. Can see this finishing around 600 IMO
ernestsyngen
05/4/2018
10:14
To any looking to profit on the bounce please be careful!
cockneytrader
05/4/2018
10:09
Woodford is anochronism - should retire together with Vec and Btg CEO‘s
a1ord53
05/4/2018
10:06
The analysts are mainly clueless graduates with above average IQs. I remember one congratulating Rolf on his successful career at BTG. I thought to myself, you don't have a clue!
cockneytrader
05/4/2018
09:58
Woodfords Btg and Vec obviously flops - he is supporting Maiking
a1ord53
05/4/2018
09:53
Annoyingly CT, you are right on this one. Stifel must be equally anoyed having raised their price target to 880p just a month ago. You wonder if the analysts get any credible guidance from the company? The curse of Woodford strikes again!!
spyder
05/4/2018
09:45
Hmmm ... shares now temporarily suspended. Just a glitch, now trading again but falling sharply.
spyder
05/4/2018
09:37
Dame ruined company imo - so many mistakes : 1 Varithena 2 Pneum x 3 manipulations and lost court Why she is still here and there FIRED
a1ord53
05/4/2018
09:19
It's a falling knife at the moment...
fhmktg
05/4/2018
08:58
Revenues might be in line but not profits. I'm with CT on this one. Varithena will need to get written down as well.
waterloo01
05/4/2018
08:21
Mainly small volume trading at the moment, no major players selling so far....could be that there are no real surprises in the statement and the 'trading in line with forecasts' is the key message.Cash is king!CT nil desperandum, your views are as valid as anybody's!
fhmktg
05/4/2018
08:13
I wish you all a good day. I truly hate these boards, as anyone with anything constructive to say to the downside is always laughed out and given thumbs down.
cockneytrader
05/4/2018
07:52
As stated the next 18 months will be painful. Both Varithena and CroFab could be next. Why? Without a relaunch Varithena is likely to fail, and Anavip becomes available in Oct 18. Expect further write downs and £55m settlement. These are worth £3-4, that's fair value given the future impacts.
cockneytrader
05/4/2018
07:36
Trying to put a brave face on it. Lung coils are dead in the water, Varithena a similar fate awaits, and CroFab under threat. No mention of settlement charge of £55m. These will bomb.
cockneytrader
03/4/2018
14:46
A message along those lines will cause a severe downgrade in sentiment and heads could roll.Significant investors would be looked no at the potential break up of the group which has been a classic growth through acquisition strategy.There is some coherence in the strategy of providing therapies to treat chronic conditions through novel methods which reduce cost to the insurers, but it's going to need a few more years of growth to achieve a sustainable level. P/E ratio of 76% calls for significant faith in Louise and her ability to deliver.If, as has been suggested, the board has been quietly grooming market players to a couple of years of little or no growth and no dividend on the horizon, then this will be a very testing year.On the other hand, everything in the interventional medicine garden could be rosy......
fhmktg
03/4/2018
14:19
The update will be interesting. My take is that Varithena will eventually bomb, CroFab is under threat, poor show from lung coils as no reimbursments exist, and it will cost £55 million in settlement (re: Wellstat). With reducing royalties, the next 18 months will be tough. Expect revenue and profit blips, along with potential write downs. Not a pretty place to be.
cockneytrader
03/4/2018
14:00
Andy Burrows is working today, he has just posted the latest bonus share listing.Perhaps the trade update is in his in tray to deal with later?
fhmktg
03/4/2018
11:35
The Telegraph had it down for today, but April 6th last year..so any day now.
fhmktg
03/4/2018
10:32
The update is pencilled in for April 2018 - a specific date was not stated. Historically, updates occur on a Thursday. Expect an update tomorrow or Thursday.
cockneytrader
03/4/2018
10:20
the update is supposed to be today- where is ti then?
ali47fish
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
Your Recent History
LSE
BTG
Btg
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 09:45:35